Abstract
Background There is a growing recognition that strategies to reduce SARS-CoV-2 transmission should be responsive to local transmission dynamics. Studies have revealed inequalities along social determinants of health, but little investigation was conducted surrounding geographic concentration within cities. We quantified social determinants of geographic concentration of COVID-19 cases across sixteen census metropolitan areas (CMA) in four Canadian provinces.
Methods We used surveillance data on confirmed COVID-19 cases at the level of dissemination area. Gini (co-Gini) coefficients were calculated by CMA based on the proportion of the population in ranks of diagnosed cases and each social determinant using census data (income, education, visible minority, recent immigration, suitable housing, and essential workers) and the corresponding share of cases. Heterogeneity was visualized using Lorenz (concentration) curves.
Results Geographic concentration was observed in all CMAs (half of the cumulative cases were concentrated among 21-35% of each city’s population): with the greatest geographic heterogeneity in Ontario CMAs (Gini coefficients, 0.32-0.47), followed by British Columbia (0.23-0.36), Manitoba (0.32), and Québec (0.28-0.37). Cases were disproportionately concentrated in areas with lower income, education attainment, and suitable housing; and higher proportion of visible minorities, recent immigrants, and essential workers. Although a consistent feature across CMAs was concentration by proportion visible minorities, the magnitude of concentration by social determinants varied across CMAs.
Interpretation The feature of geographical concentration of COVID-19 cases was consistent across CMAs, but the pattern by social determinants varied. Geographically-prioritized allocation of resources and services should be tailored to the local drivers of inequalities in transmission in response to SARS-CoV-2’s resurgence.
Competing Interest Statement
MM-G reports contractual agreements with the Institut national de santépublique du Québec (INSPQ) and the Institut d'excellence en santé et en services sociaux (INESSS).
Funding Statement
This work was supported by the Canadian Institutes of Health Research (grant no. VR5-172683).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approvals were obtained from the Research Ethics Board of University of British Columbia in British Columbia (H20-02097), the Health Research Ethics Board of University of Manitoba (HS24140 (H2020:352)) and the Health Information Privacy Committee of the Government of Manitoba (No. 2020/2021-32) in Manitoba, the Health Sciences Research Ethics Board of University of Toronto (no. 39253) in Ontario, and the Institutional Review Board of McGill University in Québec (A06-M52-20B).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest MM-G report contractual agreements with the Institut national de santé publique du Québec (INSPQ) and the Institut d’excellence en santé et en services sociaux (INESSS).
Funding This work was supported by the Canadian Institutes of Health Research (grant no. VR5- 172683).
Data Availability
COVID-19 confirmed case data used in this study is not publicly available. Data related to area-level characteristics is derived from 2016 Census Canada datasets, PCCF, and PCCF+ files.
